The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 05, 2017

Filed:

Jun. 01, 2016
Applicants:

Baxter International Inc., Deerfield, IL (US);

Baxter Healthcare, S.a., Glattpark (Opfikon), CH;

Inventors:

Jill McCoy, Sunnyvale, CA (US);

Joseph F. Dwyer, Round Lake, IL (US);

Ziping Yang, Buffalo Grove, IL (US);

Assignees:

BAXTER INTERNATIONAL INC., Deerfield, IL (US);

BAXTER HEALTHCARE S.A., Glattpark, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61L 26/00 (2006.01); A61M 5/19 (2006.01); A61K 38/17 (2006.01); A61K 38/48 (2006.01); A61K 38/38 (2006.01); A61L 24/10 (2006.01); A61K 9/06 (2006.01);
U.S. Cl.
CPC ...
A61L 26/0052 (2013.01); A61K 9/06 (2013.01); A61K 38/17 (2013.01); A61K 38/38 (2013.01); A61K 38/4833 (2013.01); A61L 24/104 (2013.01); A61L 24/108 (2013.01); A61M 5/19 (2013.01); A61L 2400/04 (2013.01); A61L 2400/06 (2013.01);
Abstract

The invention discloses a hemostatic composition comprising crosslinked gelatin in particulate form suitable for use in hemostasis, wherein the composition is present in paste form containing 15.0 to 19.5% (w/w), preferably 16.0 to 19.5% (w/w), 16.5 to 19.5% (w/w), 17.0 to 18.5% (w/w) or 17.5 to 18.5% (w/w), more preferred 16.5 to 19.0% (w/w) or 16.8 to 17.8% (w/w), especially preferred 16.5 to 17.5% (w/w), and wherein the composition comprises an extrusion enhancer.


Find Patent Forward Citations

Loading…